FASEB J. Pierce now sold as Thermo Scientific
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.06-7703com.
(The FASEB Journal. 2008;22:246-260.)
© 2008 FASEB
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
fj.06-7703comv1
22/1/246    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, W.-Q.
Right arrow Articles by Klein, W. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, W.-Q.
Right arrow Articles by Klein, W. L.
(The FASEB Journal. 2008;22:246-260.)
© 2008 FASEB

Amyloid beta oligomers induce impairment of neuronal insulin receptors

Wei-Qin Zhao*,{dagger},{ddagger},1,2, Fernanda G. De Felice*,§, Sara Fernandez*, Hui Chen||, Mary P. Lambert*, Michael J. Quon{dagger}, Grant A. Krafft{ddagger} and William L. Klein*

* Department of Neurobiology and Physiology, Northwestern University, Evanston, Illinois, USA;

{dagger} Blanchette Rockefeller Neurosciences Institute, Rockville, Maryland, USA;

{ddagger} Acumen Pharmaceuticals, South San Francisco, California, USA;

§ Institute of Medical Biochemistry, CCS/Bloco H 2nd andar Sala 019, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil; and

|| NCCAM, NIH, Bethesda, Maryland, USA

1Correspondence: Department of Neurobiology and Physiology, Northwestern University, 2205 Tech Dr., Hogan 5–110, Evanston, IL 60280, USA; E-mail: w-zhao{at}northwestern.edu

Recent studies have indicated an association between Alzheimer’s disease (AD) and central nervous system (CNS) insulin resistance. However, the cellular mechanisms underlying the link between these two pathologies have not been elucidated. Here we show that signal transduction by neuronal insulin receptors (IR) is strikingly sensitive to disruption by soluble Aβ oligomers (also known as ADDLs). ADDLs are known to accumulate in AD brain and have recently been implicated as primary candidates for initiating deterioration of synapse function, composition, and structure. Using mature cultures of hippocampal neurons, a preferred model for studies of synaptic cell biology, we found that ADDLs caused a rapid and substantial loss of neuronal surface IRs specifically on dendrites bound by ADDLs. Removal of dendritic IRs was associated with increased receptor immunoreactivity in the cell body, indicating redistribution of the receptors. The neuronal response to insulin, measured by evoked IR tyrosine autophosphorylation, was greatly inhibited by ADDLs. Inhibition also was seen with added glutamate or potassium-induced depolarization. The effects on IR function were completely blocked by NMDA receptor antagonists, tetrodotoxin, and calcium chelator BAPTA-AM. Downstream from the IR, ADDLs induced a phosphorylation of Akt at serine473, a modification associated with neurodegenerative and insulin resistance diseases. These results identify novel factors that affect neuronal IR signaling and suggest that insulin resistance in AD brain is a response to ADDLs, which disrupt insulin signaling and may cause a brain-specific form of diabetes as part of an overall pathogenic impact on CNS synapses.—Zhao, W. Q., De Felice, F. G., Fernandez, S., Chen, H., Lambert, M. P., Quon, M. J., Krafft, G. A., Klein, W. L. Amyloid beta oligomers induce impairment of neuronal insulin receptors.


Key Words: insulin resistance • calcium • NMDA receptor • receptor loss • Akt serine473 • tyrosine phosphorylation




This article has been cited by other articles:


Home page
J. Neurophysiol.Home page
V. A. Gault and C. Holscher
Protease-Resistant Glucose-Dependent Insulinotropic Polypeptide Agonists Facilitate Hippocampal LTP and Reverse the Impairment of LTP Induced by Beta-Amyloid
J Neurophysiol, April 1, 2008; 99(4): 1590 - 1595.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The Federation of American Societies for Experimental Biology.